A case study on decentralized manufacturing of 3D printed medicines
[Case study] - Losan Pharma has manufactured pharma-inks under #cGMP and delivered to a simulated point-of-care (FABRX) where quality control was conducted while printing. #3dprinting #pharmainnovation